The early innings of the obesity landscape is starting to take shape, and it seems to be forming similar patterns...
Read NowModular Medical (MODD) announced the 510(k) submission of their MODD1 insulin pump to the FDA last week. On average, the FDA takes approximately...
PremiumLong Ideas - By David Moskowitz Sunesis Pharmaceuticals (NASDAQ:SNSS) is getting the benefit of a price target increase this morning; Roth Capital raised its price target on the … Continue Reading
Read now- BioSante Pharmaceuticals (NASDAQ:BPAX) on Thursday entered into an all-stock merger agreement with emerging generic drug manufacturer, ANI Pharmaceuticals, causing BPAX shares to swing between $1.89 … Continue Reading
Read nowLong Ideas - Endo Pharmaceuticals (NASDAQ:ENDP) is hosting its analyst day today in NY, and despite guiding for lower 2013 revenues and EPS compared to Wall Street Consensus … Continue Reading
Read nowInterviews - In an exclusive PropThink interview with ARIAD Pharmaceuticals (NASDAQ:ARIA), CEO Harvey J. Berger discusses the company’s lead product, ponatinib, a potential treatment for intolerant Chronic … Continue Reading
Read nowLong Ideas - By David Moskowitz Sunesis Pharmaceuticals (NASDAQ:SNSS) has had a great year thus far, up 350% since January, and importantly, the smart money continues to flock … Continue Reading
Read nowLong Ideas - Ventrus Biosciences (NASDAQ:VTUS) recently hired JP Benya as its new VP of Commercial Operations and Business Development, with the intent that Benya will play a … Continue Reading
Read nowLong Ideas - Celgene (NASDAQ:CELG) moved closer today to securing another indication for its oncology drug, Abraxane, which is already approved as a second-line treatment for metastatic breast … Continue Reading
Read now
